Stay updated on SNDX-5613 Combo with Chemo in Relapsed Leukemia Clinical Trial
Sign up to get notified when there's something new on the SNDX-5613 Combo with Chemo in Relapsed Leukemia Clinical Trial page.

Latest updates to the SNDX-5613 Combo with Chemo in Relapsed Leukemia Clinical Trial page
- Check2 days agoChange DetectedThe study record page now displays a 403 Forbidden message, replacing the usual content and navigation. This indicates the record is not accessible and users cannot view the trial details on this page.SummaryDifference26%

- Check9 days agoChange DetectedThe page now displays revision v3.7.0 instead of v3.6.6, signaling a platform update to the study record.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedFooter revision label updated from v3.6.5 to v3.6.6, indicating a maintenance update to the ClinicalTrials.gov page. The change does not modify the study details or embedded content.SummaryDifference0.0%

- Check30 days agoChange DetectedThe study record’s update history received new entries for 2026-08-21 and 2026-08-25, while older entries for 2026-07-15 and 2026-07-16 were removed.SummaryDifference0.1%

- Check44 days agoChange DetectedThe revision tag on the page was updated to v3.6.5, replacing the previous v3.6.4, indicating a small page version update.SummaryDifference0.0%

- Check59 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, indicating a new version for internal tracking.SummaryDifference0.0%

Stay in the know with updates to SNDX-5613 Combo with Chemo in Relapsed Leukemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SNDX-5613 Combo with Chemo in Relapsed Leukemia Clinical Trial page.